CD13, a biomarker of human liver CSCs, which is associated with the self-renewal, differentiation potential, signal transduction, drug resistance, recurrence and prognosis of liver cancer stem cells (LCSCs) (Christ et al., 2011; Kim et al., 2012). This evidence concerns the gene ANPEP and liver cancer.